FARALLON CAPITAL MANAGEMENT LLC Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$16.9B
Holdings
102
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (102 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 9,290,500 | $2.7T | 15953.99% | Put |
| 2 | —AETNA INC NEW | 7,425,000 | $1.5T | 8896.66% | |
| 3 | AABAUSDALTABA INC | 21,237,317 | $1.4T | 8545.35% | |
| 4 | —EXPRESS SCRIPTS HLDG CO | 11,895,000 | $1.1T | 6675.58% | |
| 5 | DELLDELL TECHNOLOGIES INC | 6,389,000 | $620.5B | 3665.20% | |
| 6 | —ROCKWELL COLLINS INC | 4,155,000 | $583.7B | 3447.55% | |
| 7 | METAFACEBOOK INC | 2,485,943 | $408.8B | 2414.94% | |
| 8 | IQVIQVIA HLDGS INC | 3,039,386 | $394.3B | 2329.25% | |
| 9 | CHTRCHARTER COMMUNICATIONS INC N | 1,182,980 | $385.5B | 2277.15% | |
| 10 | GOOGALPHABET INC | 314,705 | $375.6B | 2218.56% | |
| 11 | WABWABTEC CORP | 3,500,600 | $367.1B | 2168.66% | |
| 12 | GDGENERAL DYNAMICS CORP | 1,770,722 | $362.5B | 2141.24% | |
| 13 | VVISA INC | 1,973,191 | $296.2B | 1749.35% | |
| 14 | PLYAPLAYA HOTELS & RESORTS NV | 30,606,930 | $294.7B | 1741.01% | |
| 15 | TLRYEURTILRAY INC | 2,479,515 | $285.5B | 1686.37% | |
| 16 | ELVANTHEM INC | 1,035,000 | $283.6B | 1675.43% | |
| 17 | —IHS MARKIT LTD | 5,055,245 | $272.8B | 1611.27% | |
| 18 | EQIXEQUINIX INC | 608,600 | $263.5B | 1556.20% | |
| 19 | —ENVISION HEALTHCARE CORP | 5,615,000 | $256.8B | 1516.72% | |
| 20 | BKNGBOOKING HLDGS INC | 128,270 | $254.5B | 1503.22% | |
| 21 | TRUTRANSUNION | 3,427,611 | $252.2B | 1489.73% | |
| 22 | MSFTMICROSOFT CORP | 2,159,213 | $246.9B | 1458.69% | |
| 23 | FOXATWENTY FIRST CENTY FOX INC | 5,360,000 | $245.6B | 1450.69% | |
| 24 | FISFIDELITY NATL INFORMATION SV | 1,961,994 | $214.0B | 1264.03% | |
| 25 | CTXSEURCITRIX SYS INC | 1,812,849 | $201.5B | 1190.32% | |
| 26 | LBTYBLIBERTY GLOBAL PLC | 6,991,640 | $196.9B | 1162.97% | |
| 27 | LBTYBLIBERTY GLOBAL PLC | 6,629,602 | $191.8B | 1132.90% | |
| 28 | VRSKVERISK ANALYTICS INC | 1,424,553 | $171.7B | 1014.38% | |
| 29 | BPYPNBROOKFIELD PROPERTY REIT INC | 8,054,215 | $168.6B | 995.75% | |
| 30 | NXPINXP SEMICONDUCTORS N V | 1,650,000 | $141.1B | 833.31% | |
| 31 | AZNASTRAZENECA PLC | 3,420,000 | $135.3B | 799.37% | |
| 32 | EFXEQUIFAX INC | 815,817 | $106.5B | 629.20% | |
| 33 | XLRNACCELERON PHARMA INC | 1,840,732 | $105.3B | 622.26% | |
| 34 | ASNDASCENDIS PHARMA A S | 1,457,297 | $103.3B | 609.96% | |
| 35 | —MYOKARDIA INC | 1,531,278 | $99.8B | 589.73% | |
| 36 | —ZOGENIX INC | 1,795,500 | $89.1B | 526.05% | |
| 37 | SG7SAGE THERAPEUTICS INC | 625,000 | $88.3B | 521.46% | |
| 38 | FGENEURFIBROGEN INC | 1,395,000 | $84.7B | 500.58% | |
| 39 | —SINA CORP | 1,124,224 | $78.1B | 461.39% | |
| 40 | ARRYEURARRAY BIOPHARMA INC | 5,125,000 | $77.9B | 460.14% | |
| 41 | AVAAVISTA CORP | 1,470,000 | $74.3B | 439.01% | |
| 42 | ENTAENANTA PHARMACEUTICALS INC | 867,500 | $74.1B | 437.92% | |
| 43 | NVCRNOVOCURE LTD | 1,350,000 | $70.7B | 417.85% | |
| 44 | —TWENTY FIRST CENTY FOX INC | 1,435,000 | $66.5B | 392.71% | |
| 45 | BABAALIBABA GROUP HLDG LTD | 373,000 | $61.5B | 363.01% | |
| 46 | CLSCA INC | 1,382,361 | $61.0B | 360.50% | |
| 47 | RETAEURREATA PHARMACEUTICALS INC | 673,500 | $55.1B | 325.26% | |
| 48 | AMRNAMARIN CORP PLC | 3,312,700 | $53.9B | 318.37% | |
| 49 | IOVAIOVANCE BIOTHERAPEUTICS INC | 4,725,000 | $53.2B | 313.98% | |
| 50 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,370,000 | $52.1B | 307.51% | |
| 51 | CRSPCRISPR THERAPEUTICS AG | 1,018,594 | $45.2B | 266.84% | |
| 52 | MRTXEURMIRATI THERAPEUTICS INC | 875,000 | $41.2B | 243.44% | |
| 53 | GRFSGRIFOLS S A | 1,790,000 | $38.3B | 225.95% | |
| 54 | —SUTHERLAND ASSET MGMT CORP M | 2,203,239 | $36.7B | 216.69% | |
| 55 | —RADIUS HEALTH INC | 2,043,149 | $36.4B | 214.82% | |
| 56 | SRPTSAREPTA THERAPEUTICS INC | 195,000 | $31.5B | 186.03% | |
| 57 | —INTEGRATED DEVICE TECHNOLOGY | 640,000 | $30.1B | 177.71% | |
| 58 | YB4PSAVARA INC | 2,418,009 | $27.0B | 159.40% | |
| 59 | BUDANHEUSER BUSCH INBEV SA/NV | 293,109 | $25.7B | 151.62% | |
| 60 | ALNYALNYLAM PHARMACEUTICALS INC | 276,551 | $24.2B | 142.97% | |
| 61 | —AVROBIO INC | 465,000 | $24.1B | 142.47% | |
| 62 | PTGXPROTAGONIST THERAPEUTICS INC | 2,243,202 | $23.1B | 136.35% | |
| 63 | —PROGENICS PHARMACEUTICALS IN | 3,612,820 | $22.7B | 133.80% | |
| 64 | —PTC THERAPEUTICS INC | 18,350,000 | $21.1B | 124.72% | |
| 65 | —ZYMEWORKS INC | 1,335,000 | $21.0B | 123.81% | |
| 66 | PTCTPTC THERAPEUTICS INC | 420,000 | $19.7B | 116.60% | |
| 67 | —APTINYX INC | 670,000 | $19.4B | 114.61% | |
| 68 | EX9EXELIXIS INC | 1,080,000 | $19.1B | 113.05% | |
| 69 | —ZAFGEN INC | 1,625,000 | $19.0B | 112.21% | |
| 70 | PBYIPUMA BIOTECHNOLOGY INC | 410,000 | $18.8B | 111.04% | |
| 71 | VYGRVOYAGER THERAPEUTICS INC | 909,158 | $17.2B | 101.60% | |
| 72 | CDXSCODEXIS INC | 1,000,000 | $17.1B | 101.30% | |
| 73 | —BROOKFIELD PPTY PARTNERS L P | 794,382 | $16.6B | 98.02% | |
| 74 | —SHIRE PLC | 87,000 | $15.8B | 93.15% | |
| 75 | NTLAINTELLIA THERAPEUTICS INC | 550,000 | $15.7B | 92.98% | |
| 76 | —ZEALAND PHARMA A S | 900,000 | $14.9B | 87.82% | |
| 77 | CCXIEURCHEMOCENTRYX INC | 1,150,000 | $14.5B | 85.86% | |
| 78 | SLDBSOLID BIOSCIENCES INC | 295,000 | $13.9B | 82.21% | |
| 79 | —ORBOTECH LTD | 230,000 | $13.7B | 80.75% | |
| 80 | DVAXDYNAVAX TECHNOLOGIES CORP | 1,070,000 | $13.3B | 78.37% | |
| 81 | —BELLICUM PHARMACEUTICALS INC | 2,136,629 | $13.2B | 77.75% | |
| 82 | CHRSCOHERUS BIOSCIENCES INC | 700,000 | $11.6B | 68.22% | |
| 83 | ASMBASSEMBLY BIOSCIENCES INC | 300,000 | $11.1B | 65.81% | |
| 84 | —BEMIS INC | 206,660 | $10.0B | 59.33% | |
| 85 | VOYAVOYA FINL INC | 185,000 | $9.2B | 54.28% | |
| 86 | FATEFATE THERAPEUTICS INC | 530,000 | $8.6B | 51.00% | |
| 87 | —ENDOCYTE INC | 400,000 | $7.1B | 41.96% | |
| 88 | ITCIEURINTRA CELLULAR THERAPIES INC | 250,000 | $5.4B | 32.04% | |
| 89 | —SOLARCITY CORP | 5,000,000 | $4.9B | 29.13% | |
| 90 | —TRANSLATE BIO INC | 450,000 | $4.5B | 26.58% | |
| 91 | KALVKALVISTA PHARMACEUTICALS INC | 200,000 | $4.4B | 26.12% | |
| 92 | SPPIUSDSPECTRUM PHARMACEUTICALS INC | 250,000 | $4.2B | 24.81% | |
| 93 | CRNXCRINETICS PHARMACEUTICALS IN | 141,815 | $4.1B | 24.00% | |
| 94 | SNYSANOFI | 6,827,805 | $3.8B | 22.58% | |
| 95 | —PRINCIPIA BIOPHARMA INC | 125,000 | $3.7B | 21.58% | |
| 96 | YMABUSDY MABS THERAPEUTICS INC | 125,000 | $3.3B | 19.61% | |
| 97 | —PFENEX INC | 600,000 | $3.1B | 18.11% | |
| 98 | —ARQULE INC | 500,000 | $2.8B | 16.72% | |
| 99 | —RA MED SYS INC | 150,000 | $2.7B | 16.13% | |
| 100 | STROSUTRO BIOPHARMA INC | 150,000 | $2.3B | 13.29% |
Page 1 of 2Next